Nordea Investment Management
ALLO icon

Nordea Investment Management’s Allogene Therapeutics ALLO Stock Holding History

Nordea Investment Management’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-460,641
Closed -$986K – 879
2024
Q4 		$986K Buy
460,641
+9,635
+2% +$23.8K ﹤0.01% 810
2024
Q3 		$1.3M Sell
451,006
-183,654
-29% -$490K ﹤0.01% 773
2024
Q2 		$1.48M Sell
634,660
-107,454
-14% -$317K ﹤0.01% 747
2024
Q1 		$3.38M Buy
742,114
+1,431
+0.2% +$5.97K ﹤0.01% 618
2023
Q4 		$2.38M Sell
740,683
-23,805
-3% -$67.5K ﹤0.01% 673
2023
Q3 		$2.42M Sell
764,488
-10,807
-1% -$47.4K ﹤0.01% 660
2023
Q2 		$3.73M Buy
775,295
+129,667
+20% +$701K 0.01% 578
2023
Q1 		$3.25M Sell
645,628
-7,187
-1% -$46.1K ﹤0.01% 606
2022
Q4 		$3.9M Sell
652,815
-11,487
-2% -$106K 0.01% 567
2022
Q3 		$6.96M Sell
664,302
-34,906
-5% -$474K 0.01% 438
2022
Q2 		$7.87M Sell
699,208
-60,468
-8% -$537K 0.01% 420
2022
Q1 		$7.28M Buy
759,676
+342,237
+82% +$3.56M 0.01% 503
2021
Q4 		$6.46M Buy
417,439
+112,028
+37% +$1.98M 0.01% 533
2021
Q3 		$7.92M Sell
305,411
-5,895
-2% -$140K 0.01% 468
2021
Q2 		$8.12M Buy
311,306
+142,323
+84% +$4.06M 0.01% 458
2021
Q1 		$5.93M Sell
168,983
-6,823
-4% -$230K 0.01% 549
2020
Q4 		$4.44M Sell
175,806
-3,438
-2% -$112K 0.01% 598
2020
Q3 		$6.72M Sell
179,244
-176,302
-50% -$6.65M 0.01% 388
2020
Q2 		$14.9M Buy
355,546
+177,777
+100% +$6.43M 0.02% 357
2020
Q1 		$3.46M Buy
177,769
+6,638
+4% +$158K 0.01% 533
2019
Q4 		$4.47M Buy
+171,131
New +$4.71M 0.01% 582

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management's ALLO Position: Q1 2025 in Review

Nordea Investment Management sold out of Allogene Therapeutics (ALLO) in Q1 2025, closing a stake of 460,641 shares — an estimated $986K sold.

Nordea Investment Management first reported a position in ALLO in Q4 2019 and held it in 21 quarters. The position peaked at $14.9M in Q2 2020. 170 funds tracked by Wall St. Rank hold ALLO as of Q1 2025.

  • Nordea Investment Management reported no remaining Allogene Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Nordea Investment Management sold 460,641 Allogene Therapeutics shares in Q1 2025, an estimated $986K.
  • Nordea Investment Management first reported a position in Allogene Therapeutics in Q4 2019 and held it in 21 quarters.
  • Nordea Investment Management's Allogene Therapeutics position peaked at $14.9M in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2025.

Based on Nordea Investment Management's 13F filing for Q1 2025, filed 14 May 2025.